Literature DB >> 26312457

Liver regeneration following experimental major hepatectomy with choledochojejunostomy.

T Takagi1, Y Yokoyama1, T Kokuryo1, J Yamaguchi1, M Nagino1.   

Abstract

BACKGROUND: Surgical treatment for perihilar cholangiocarcinoma frequently involves hepatectomy and extrahepatic bile duct resection with a choledochojejunostomy (CJ). Cholangitis owing to bilioenteric anastomosis is a common complication. The impact of CJ or regurgitating cholangitis on the liver regeneration process after major hepatectomy is unknown.
METHODS: Rats underwent 70 per cent hepatectomy (Hx group) or hepatectomy with CJ (Hx + CJ group). The intrahepatic inflammatory response, hepatic regeneration rate, and expression of regeneration-associated genes in the liver and blood were compared between these two groups.
RESULTS: Levels of hepatobiliary markers in the blood were significantly higher 4 and 7 days after operation in the Hx + CJ group than the Hx group. Intrahepatic expression of inflammation-associated genes, such as interleukin 6 and tumour necrosis factor α, was also significantly higher in the Hx + CJ group on days 4 and 7. A progressive periportal inflammatory response was identified in the Hx + CJ group by histological examination. The hepatic regeneration rate was significantly lower in the Hx + CJ group than in the Hx group on day 2 (mean(s.d.) 14·2(6·3) versus 21·4(2·6) per cent; P = 0·013) and day 4 (32·4(5·3) versus 41·3(4·4) per cent; P = 0·004). Gene expression levels of hepatic regeneration-promoting factors such as hepatocyte growth factor were significantly lower in the Hx + CJ group than the Hx group on day 1.
CONCLUSION: CJ perturbs early liver regeneration after hepatectomy. An excessive inflammatory response in the liver and suppression of liver regeneration-associated factors may play a role. Surgical relevance Patients with perihilar cholangiocarcinoma may need major hepatectomy with extrahepatic bile duct resection and choledochojejunostomy. This carries a substantial risk of postoperative complications including liver failure. A rat model of partial hepatectomy with choledochojejunostomy was established. The molecular mechanisms underlying liver regeneration, and perturbation of this process by duodenobiliary reflux via the choledochojejunostomy, are described. The results give insight into the pathophysiological events following major hepatectomy with extrahepatic bile duct resection and choledochojejunostomy. This may help to develop a treatment strategy to reduce postoperative liver failure.
© 2015 BJS Society Ltd Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26312457     DOI: 10.1002/bjs.9908

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

1.  A Clear Difference Between the Outcomes After a Major Hepatectomy With and Without an Extrahepatic Bile Duct Resection.

Authors:  Takehiro Takagi; Yukihiro Yokoyama; Toshio Kokuryo; Tomoki Ebata; Masahiko Ando; Masato Nagino
Journal:  World J Surg       Date:  2017-02       Impact factor: 3.352

2.  Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma.

Authors:  Takehiro Noji; Satoko Uemura; Jimme K Wiggers; Kimitaka Tanaka; Yoshitsugu Nakanishi; Toshimichi Asano; Toru Nakamura; Takahiro Tsuchikawa; Keisuke Okamura; Pim B Olthof; William R Jarnagin; Thomas M van Gulik; Satoshi Hirano
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

Review 3.  Issues to be considered to address the future liver remnant prior to major hepatectomy.

Authors:  Yoji Kishi; Jean-Nicolas Vauthey
Journal:  Surg Today       Date:  2020-09-07       Impact factor: 2.549

4.  Therapeutic targets for liver regeneration after acute severe injury: a preclinical overview.

Authors:  Hidenobu Kojima; Kojiro Nakamura; Jerzy W Kupiec-Weglinski
Journal:  Expert Opin Ther Targets       Date:  2020-01-10       Impact factor: 6.902

5.  A simple rat model of in situ reversible obstructive jaundice in situ reversible obstructive jaundice model.

Authors:  Xin Huang; Chong-Hui Li; Ai-Qun Zhang; Zhe Kong; Wan-Qing Gu; Jia-Hong Dong
Journal:  Ann Surg Treat Res       Date:  2017-05-29       Impact factor: 1.859

6.  Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma.

Authors:  Tianyi Fang; Hao Wang; Yunfu Cui; Zhidong Wang; Yufu Wang; Xuan Lin
Journal:  Dis Markers       Date:  2019-02-04       Impact factor: 3.464

Review 7.  Liver Regeneration after Hepatectomy and Partial Liver Transplantation.

Authors:  Shintaro Yagi; Masaaki Hirata; Yosuke Miyachi; Shinji Uemoto
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

8.  The Impact of Biliary Reconstruction Methods on Small Partial Liver Grafts.

Authors:  Junichi Yoshikawa; Koichiro Hata; Kojiro Nakamura; Yusuke Okamura; Shinji Uemoto
Journal:  Transplant Direct       Date:  2020-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.